Loading
TAMPA — HedgePath Pharmaceuticals Inc. has started enrolling patients for a clinical trial for a potential cancer treatment.
Click here to Subscribe
Click here to Login
Start your day with the top Gulf Coast business news you need to succeed.
Stay updated with a weekly roundup of big deals, market shifts and the people shaping commercial real estate from Tampa Bay to Naples.